Quantbot Technologies LP Immuno Gen, Inc. Transaction History

Quantbot Technologies LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $3,899 - $9,374	313 Added 4.36%	7,500 $222,000
Q3 2023 Nov 07, 2023	SELL	$14.09 - $19.87 $55,824 - $78,724	-3,962 Reduced 35.54%	7,187 $114,000
Q2 2023 Aug 08, 2023	BUY	$3.75 - $20.05 $41,808 - $223,537	11,149 New	11,149 $210,000
Q3 2022 Nov 07, 2022	BUY	$4.48 - $6.47 $199,808 - $288,562	44,600 New	44,600 $213,000
Q2 2021 Aug 12, 2021	SELL	$5.79 - $8.6 $60,986 - $90,583	-10,533 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$6.5 - $10.53 $67,814 - $109,859	10,433 Added 10433.0%	10,533 $85,000
Q4 2020 Feb 12, 2021	BUY	$3.7 - $7.66 $370 - $766	100 New	100 $0
Q2 2020 Aug 13, 2020	SELL	$3.32 - $5.34 $3,034 - $4,880	-914 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.12 - $6.8 $1,937 - $6,215	914 New	914 $3,000
Q4 2019 Feb 10, 2020	SELL	$2.25 - $5.8 $1,455 - $3,752	-647 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.22 - $3.39 $1,436 - $2,193	647 New	647 $1,000
Q4 2018 Feb 13, 2019	SELL	$3.94 - $9.7 $66,148 - $162,853	-16,789 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$8.6 - $11.26 $62,057 - $81,252	7,216 Added 75.38%	16,789 $158,000
Q2 2018 Aug 13, 2018	BUY	$9.52 - $12.15 $12,461 - $15,904	1,309 Added 15.84%	9,573 $93,000
Q1 2018 May 11, 2018	BUY	$6.7 - $12.95 $55,368 - $107,018	8,264 New	8,264 $86,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.